Genmab Financial Statements From 2010 to 2026

GE9 Stock  EUR 270.50  2.10  0.77%   
Genmab A/S's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Genmab A/S's valuation are provided below:
Gross Profit
3.6 B
Profit Margin
0.4117
Market Capitalization
17.2 B
Revenue
3.8 B
Earnings Share
4.859
There are over one hundred nineteen available fundamental trends for Genmab A/S, which can be analyzed over time and compared to other ratios. Active traders should verify all of Genmab A/S regular fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.

Genmab A/S Total Revenue

6.48 Billion

Check Genmab A/S financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genmab A/S's main balance sheet or income statement drivers, such as Discontinued Operations of 33.8 M, Interest Expense of 0.0 or Selling General Administrative of 413 M, as well as many indicators such as Price To Sales Ratio of 4.9, Dividend Yield of 0.0 or PTB Ratio of 2.25. Genmab financial statements analysis is a perfect complement when working with Genmab A/S Valuation or Volatility modules.
  
This module can also supplement various Genmab A/S Technical models . Check out the analysis of Genmab A/S Correlation against competitors.

Genmab A/S Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets18.3 B17.4 B9.4 B
Slightly volatile
Other Current Liabilities2.1 BB1.1 B
Slightly volatile
Total Current Liabilities2.2 B2.1 B1.1 B
Slightly volatile
Total Stockholder Equity17 B16.2 B8.5 B
Slightly volatile
Other Liabilities592.9 M564.6 M263 M
Slightly volatile
Net Tangible Assets33 B31.4 B13.3 B
Slightly volatile
Cash4.3 B4.1 BB
Slightly volatile
Other Assets198.5 M345 M175.8 M
Slightly volatile
Net Receivables7.3 BB2.7 B
Slightly volatile
Short Term InvestmentsB8.5 BB
Slightly volatile
Other Stockholder Equity69.1 M88.2 M85.2 M
Pretty Stable
Total Liabilities526.5 M986.4 M871.5 M
Very volatile
Short and Long Term Debt100.9 K106.2 K687.2 K
Slightly volatile
Total Current Assets34.3 B32.6 B14.1 B
Slightly volatile
Short Term Debt100.9 K106.2 K687.2 K
Slightly volatile
Intangible Assets567.5 M540.5 M292.3 M
Slightly volatile
Common Stock67.5 M75.9 M61.4 M
Slightly volatile
Property Plant Equipment1.6 B1.5 B568.3 M
Slightly volatile
Accounts Payable422.6 M402.5 M225.8 M
Slightly volatile
Long Term Investments119.2 M134.1 M146.4 M
Slightly volatile

Genmab A/S Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Discontinued Operations33.8 M38 M41.5 M
Slightly volatile
Selling General Administrative413 M393.3 M221.1 M
Slightly volatile
Total Revenue6.5 B6.2 B3.3 B
Slightly volatile
Gross Profit6.5 B6.2 B3.3 B
Slightly volatile
Operating Income3.2 BB1.6 B
Slightly volatile
Net Income From Continuing Ops2.6 B2.5 B1.4 B
Slightly volatile
EBIT7.7 B7.4 BB
Slightly volatile
Research Development2.9 B2.7 B1.5 B
Slightly volatile
Total Operating Expenses3.3 B3.1 B1.7 B
Slightly volatile
Income Before Tax3.5 B3.3 B1.7 B
Slightly volatile
Net Income Applicable To Common Shares6.7 B6.4 B2.6 B
Slightly volatile
Net Income2.6 B2.5 B1.4 B
Slightly volatile

Genmab A/S Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock366 M193.4 M283.4 M
Pretty Stable
Depreciation480.6 M457.7 M184.5 M
Slightly volatile
Net Income5.3 BB2.3 B
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.95.1517.2507
Slightly volatile
PTB Ratio2.252.377.602
Slightly volatile
Days Sales Outstanding231130243
Slightly volatile
Book Value Per Share537511228
Slightly volatile
Average Payables27.4 M19.3 M19.5 M
Slightly volatile
Stock Based Compensation To Revenue0.03440.03850.0334
Pretty Stable
Capex To Depreciation0.390.411.6626
Slightly volatile
PB Ratio2.252.377.602
Slightly volatile
EV To Sales4.454.6816.5479
Slightly volatile
Inventory Turnover15.0114.35.7736
Slightly volatile
Days Of Inventory On Hand25.126.4289.9951
Slightly volatile
Payables Turnover0.310.331.0897
Slightly volatile
Sales General And Administrative To Revenue0.07140.07520.1337
Slightly volatile
Research And Ddevelopement To Revenue0.490.520.8394
Slightly volatile
Capex To Revenue0.00950.010.0497
Slightly volatile
Cash Per Share309294169
Slightly volatile
Days Payables Outstanding9181.2 K2.9 K
Very volatile
Intangibles To Total Assets0.310.290.0715
Slightly volatile
Current Ratio7.344.729.6721
Slightly volatile
Tangible Book Value Per Share319304187
Slightly volatile
Receivables Turnover4.23.73.6277
Pretty Stable
Graham Number1.2 K1.1 K476
Slightly volatile
Shareholders Equity Per Share537511228
Slightly volatile
Debt To Equity0.01570.02520.015
Slightly volatile
Capex Per Share1.582.62.7371
Slightly volatile
Graham Net Net249237157
Slightly volatile
Revenue Per Share315300116
Slightly volatile
Interest Debt Per Share16.816.05.5129
Slightly volatile
Debt To Assets0.01020.02020.0115
Slightly volatile
Operating Cycle251157252
Slightly volatile
Price Book Value Ratio2.252.377.602
Slightly volatile
Days Of Payables Outstanding9181.2 K2.9 K
Very volatile
Ebt Per Ebit0.791.231.038
Slightly volatile
Company Equity Multiplier1.681.441.588
Slightly volatile
Total Debt To Capitalization0.0150.02450.0147
Slightly volatile
Debt Equity Ratio0.01570.02520.015
Slightly volatile
Quick Ratio7.344.719.6695
Slightly volatile
Net Income Per E B T1.430.981.293
Slightly volatile
Cash Ratio1.91.672.5142
Slightly volatile
Days Of Inventory Outstanding25.126.4289.9951
Slightly volatile
Days Of Sales Outstanding231130243
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.021.120.9063
Very volatile
Price To Book Ratio2.252.377.602
Slightly volatile
Fixed Asset Turnover12.3810.2518.7434
Slightly volatile
Debt Ratio0.01020.02020.0115
Slightly volatile
Price Sales Ratio4.95.1517.2507
Slightly volatile
Asset Turnover0.220.420.3435
Slightly volatile
Price Fair Value2.252.377.602
Slightly volatile

About Genmab A/S Financial Statements

Genmab A/S stakeholders use historical fundamental indicators, such as Genmab A/S's revenue or net income, to determine how well the company is positioned to perform in the future. Although Genmab A/S investors may analyze each financial statement separately, they are all interrelated. For example, changes in Genmab A/S's assets and liabilities are reflected in the revenues and expenses on Genmab A/S's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Genmab AS. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue6.2 B6.5 B
Stock Based Compensation To Revenue 0.04  0.03 
Sales General And Administrative To Revenue 0.08  0.07 
Research And Ddevelopement To Revenue 0.52  0.49 
Capex To Revenue 0.01  0.01 
Revenue Per Share 299.74  314.73 
Ebit Per Revenue 0.36  0.34 

Currently Active Assets on Macroaxis

When determining whether Genmab A/S offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genmab A/S's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genmab As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genmab As Stock:
Check out the analysis of Genmab A/S Correlation against competitors.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Please note, there is a significant difference between Genmab A/S's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genmab A/S is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Genmab A/S's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.